Agusta 2023: Haɗin ƙayyadaddun ƙayyadaddun adadin niraparib da abiraterone acetate (Akeega, Janssen Biotech, Inc.), tare da prednisone, Cibiyar Abinci da Magunguna ta amince da ita ga manya marasa lafiya da castration-resista.
Agusta 2022: Darolutamide (Nubeqa, Bayer HealthCare Pharmaceuticals Inc.) allunan haɗe tare da docetaxel an amince da su ta Hukumar Abinci da Magunguna don manya marasa lafiya da ciwon gurguwar ƙwayar cuta (mHS..
Afrilu 2022: Hukumar Abinci da Magunguna ta amince da Pluvicto (lutetium Lu 177 vipivotide tetraxetan, Advanced Accelerator Applications USA, Inc., kamfanin Novartis) don kula da manya marasa lafiya tare da takamaiman mem na prostate.
Maris 2022: HIFU (High Intensity Focused Duban dan tayi) wani yankan-baki far ne da yin amfani da mayar da hankali, high-makamashi duban dan tayi taguwar ruwa don zafi da kashe cancerous sassa na prostate gland shine yake. Naman da aka yi niyya yana mai zafi zuwa digiri 880 zuwa 980.
Agusta 2021: Mai karɓar raunin gonadotropin na farko (GnRH) antagonist receptor, relugolix (ORGOVYX, Myovant Sciences, Inc.), Hukumar Abinci da Magunguna ta amince da shi a ranar 18 ga Disamba, 2020, don manya marasa lafiya da saduwa.